Chongqing Zhifei Biological Products Co., Ltd. (300122)
Market Closed
10 Aug, 06:57
XSHE XSHE Primary ¥
13. 35
-0.13
-0.9644%
¥
49.22B Market Cap
7.25 P/E Ratio
0.8% Div Yield
30.94M Volume
3.96 Eps
¥ 13.48
Previous Close Want to track 300122 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
300122 closed today lower at ¥13.35, a decrease of -0.9644% from yesterday's close, completing a monthly increase of 14.2979% or ¥1.67. Over the past 12 months, 300122 stock lost -29.3651%.
300122 is not paying dividends to its shareholders.
The last earnings report, released on Apr 28, 2026, exceeded the consensus estimates by 2.3803%. On average, the company has surpassed earnings expectations by 0.6273%, based on the last three reports.
Chongqing Zhifei Biological Products Co., Ltd. has completed 3 stock splits, with the recent split occurring on Jun 16, 2023.
The company's stock is traded on one exchange.
300122 Chart
People also search for
Chongqing Zhifei Biological Products Co., Ltd. (300122) FAQ
What is the stock price today?
The current price is ¥13.35.
On which exchange is it traded?
Chongqing Zhifei Biological Products Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 300122.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.8%.
What is its market cap?
As of today, the market cap is 49.22B.
Has Chongqing Zhifei Biological Products Co., Ltd. ever had a stock split?
Chongqing Zhifei Biological Products Co., Ltd. had 3 splits and the recent split was on Jun 16, 2023.
Chongqing Zhifei Biological Products Co., Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Lingfeng Jiang CEO | XSHE Exchange | CNE100000V20 ISIN |
| CN Country | 7,220 Employees | 25 Dec 2024 Last Dividend | 13 May 2016 Last Split | 28 Sep 2010 IPO Date |
Overview
Chongqing Zhifei Biological Products Co., Ltd., founded in 2002 and based in Chongqing, China, specializes in the research, development, manufacture, marketing, distribution, import, and export of vaccines and biological products. The company is committed to enhancing public health through its contributions to the biopharmaceutical sector. It has established a significant presence in China’s healthcare industry, offering a wide range of biological products vital for disease prevention and control. Moreover, it extends its logistical capabilities by providing cold storage services, ensuring the integrity and efficacy of temperature-sensitive biological products throughout their lifecycle.
Products and Services
- Vaccines - Chongqing Zhifei Biological Products Co., Ltd. is deeply involved in the development of vaccines that target various infectious diseases. By focusing on immunization, the company plays a crucial role in preventing the spread of illnesses, thus contributing to public health safety. Their portfolio includes vaccines for influenza, hepatitis, and other prevalent infections, all manufactured under stringent safety standards to assure quality and efficacy.
- Biological Products - Beyond vaccines, the company also manufactures a broad range of biological products. These include but are not limited to, blood derivatives, monoclonal antibodies, and recombinant proteins. These products have applications in diagnostics, therapeutics, and research, highlighting the company's versatility and commitment to advancing biotechnological innovations.
- Cold Storage Services - Recognizing the critical need for proper storage conditions for vaccines and biological products, Chongqing Zhifei Biological Products Co., Ltd. offers cold storage services. This service ensures that products retain their potency and safety from manufacture to delivery, catering to both its products and the needs of other entities requiring specialized cold chain logistics.
Contact Information
Address: Building T1, Chongqing, China, 400020
Phone: 86 23 8635 8685
Website: https://www.zhifeishengwu.com
